George Sleem
About George Sleem
George Sleem is a Bioanalytical Scientist at Bristol Myers Squibb in Warren, New Jersey, with extensive experience in various scientific roles and expertise in functional assays and analytical testing methods.
Bioanalytical Scientist at Bristol Myers Squibb
George Sleem currently holds the position of Bioanalytical Scientist at Bristol Myers Squibb, located in Warren, New Jersey, United States. His role involves supporting quality control investigations and contributing to studies for regulatory filing. Sleem utilizes scientific principles to aid in analytical testing methods and ensures the proper use of laboratory equipment. He performs peer reviews of testing data and maintains records in an electronic notebook (ELN).
Previous Experience at Accurant Biotech, Inc.
Before joining Bristol Myers Squibb, George Sleem worked as an Associate Scientist at Accurant Biotech, Inc. for 8 months in 2021-2022. During his tenure, he gained valuable experience in bioanalytical methods and contributed to the company's scientific endeavors.
R&D Associate Scientist at Intertek
In 2021, George Sleem served as a Research & Development Associate Scientist at Intertek for a brief period of 4 months. His role at Intertek involved supporting R&D projects and leveraging his bioanalytical expertise to assist in various scientific research initiatives.
Scientist at Antylia Scientific
From 2018 to 2021, George Sleem was employed as a Scientist at Antylia Scientific in Metuchen, New Jersey. Over the course of three years, he honed his skills and contributed significantly to the company's scientific projects. He focused on areas such as assay development and biomarker analysis.
Educational Background in Biochemistry
George Sleem holds a Bachelor's degree in Biochemistry from Alexandria University. His academic background has provided him with the foundational knowledge required for his career in bioanalytical science and has been instrumental in his professional development.
Expertise in Functional and Immunophenotype Assays
George Sleem is a subject matter expert for functional assays that test for biomarker expression upregulation. He supports IPV assays to identify the purity and viability of specific T-cell biomarkers using the MACSQUANT Analyzer. He also performs INF-y assays to measure cytokine levels in supernatants from CAR-T activation using the ELLA instrument. Additionally, he runs immunophenotype assays using the BD FACSymphony A5 to identify biomarkers in cell suspensions.
Molecular Team Contributions
Sleem supports the molecular team by running qPCR assays to determine the Vector Copy Number (VCN) in drug products. His contributions are crucial for ensuring the accuracy and integrity of molecular analysis required in bioanalytical studies.